リリースコンテナ第3倉庫

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=687972

Fitch Ratings has published updated recovery analyses for U.S. media and entertainment companies.

Effective Aug. 10, 2012 Fitch Ratings updated its Ratings Definitions, expanding the application of '+/-' to corporate issue ratings at the 'CCC' level and defining a rating action 'Under Review'. The '+/-' designations at the 'CCC' level are limited to instrument ratings and will not be used for Issuer Default Ratings, leaving 'CCC' as the sole issuer rating within the 'CCC' category. The new designations provide greater comparability to debt instruments and recovery ratings in the lower end of the speculative-grade rating scale, and are not intended to reflect any change in Fitch's view of the creditworthiness of the issuers or instruments changed in this rating action.

Media and entertainment companies with issue and recovery ratings affected by the change in the scale include AMC Entertainment Inc., Clear Channel Communications, Inc., The McClatchy Company, and Univision Communications, Inc.

U.S. Media and Entertainment Recovery Models - Second-Quarter 2012

--AMC Entertainment Inc.

--Regal Entertainment Group

--Clear Channel Communications, Inc.

--Clear Channel Worldwide Holdings Inc.

--The McClatchy Company

--Univision Communications, Inc.

The interactive recovery analysis worksheets are available at 'www.fitchratings.com' under the following headers:

Sectors then Corporate Finance then Corporates then Research

Additional information is available 'www.fitchratings.com'.

Applicable Criteria and Related Research:

--'Recovery Ratings and Notching Criteria for Nonfinancial Corporate Issuers', August 14, 2012;

--'Corporate Rating Methodology', Aug. 08, 2012;

--'Parent and Subsidiary Rating Linkage', Aug. 12, 2011;

--'U.S. Media & Entertainment Sector - Recovery Rating and Notching Methodology', Feb. 16, 2010';

--'Operating Leases: Updated Implications for Lessees' Credit', Aug. 5, 2011;

--'Impact of Receivables Securitization on Debt Recovery Ratings of Highly Leveraged Issuers', May 12, 2011.

Applicable Criteria and Related Research:

Recovery Ratings and Notching Criteria for Non-Financial Corporate Issuers

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=686476

Corporate Rating Methodology

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=684460

Parent and Subsidiary Rating Linkage

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=685552

U.S. Media & Entertainment Sector -- Recovery Rating and Notching Methodology

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=500236

Operating Leases: Updated Implications for Lessees' Credit

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=462222

Impact of Receivables Securitisation on Debt Recovery Ratings of Highly Leveraged Issuers

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=677743

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE.

“We are very happy to have Kate join our team”

Aragon brings 12 years of retirement plans expertise to The Standard and the advisors she serves. She has gained broad experience through her work in various areas of the retirement industry, including ERISA consulting, plan design, compliance and plan administration.

“We are very happy to have Kate join our team,” said Kendell Adler, regional service manager for The Standard’s Central region. “Kate comes to The Standard from a relationship management role in which she also had to juggle plan administration and compliance-related responsibilities. She successfully maintained a high level of client and advisor satisfaction while fulfilling dual responsibilities. In a more focused role at The Standard, she will channel her skills and well-rounded knowledge solely towards supporting her advisors and their clients.”

Aragon earned a bachelor’s degree in business administration from Regis University. She holds a Series 6 securities license and is pursuing a Series 65 license. Aragon has also completed tests to be awarded the Qualified 401(k) Administrator (QKA) designation from the American Society of Pension Professionals & Actuaries (ASPPA).

Disclosure

StanCorp Equities, Inc., member FINRA, distributes group annuity contracts issued by Standard Insurance Company and may provide other brokerage services. Third party administrative services are provided by Standard Retirement Services, Inc. Investment advisory services are provided by StanCorp Investment Advisers, Inc., a registered investment advisor.

About The Standard

The Standard is a leading provider of financial products and services, including group and individual disability insurance, group life and accidental death and dismemberment insurance, group dental and vision insurance, absence management services, retirement plans products and services, individual annuities and investment advice. For more information about The Standard, visit www.standard.com.

The Standard is the marketing name for StanCorp Financial Group, Inc. and its subsidiaries: Standard Insurance Company, The Standard Life Insurance Company of New York, Standard Retirement Services, Inc., StanCorp Mortgage Investors, Inc., StanCorp Investment Advisers, Inc., StanCorp Real Estate, LLC, and StanCorp Equities, Inc.

“We are excited to have the opportunity to acquire a well-respected, client-focused, quality organization such as Summit Builders and look forward to continuing to provide quality services focused on exceeding client expectations”

This acquisition unites both dck’s and Summit’s capabilities and market reach through their combined resources and allows Summit dck to focus its efforts in the southwestern region (including Arizona, California, New Mexico, and Texas) where Summit has been establishing a strong presence and culture.

“We are excited to have the opportunity to acquire a well-respected, client-focused, quality organization such as Summit Builders and look forward to continuing to provide quality services focused on exceeding client expectations,” said Stephen D’Angelo, CEO and President of dck worldwide.

Summit Builders is a general contractor based in Phoenix, Arizona, that has successfully provided preconstruction and construction services for the last 26 years to markets such as hospitality, retail, commercial, education, healthcare, and multi-family for private, public, and federal clients. Summit has consistently generated annual revenue in excess of $200 million, including $180 million of revenue in the last 12 months.

“Combining the depth, creativity, and strength of dck worldwide with Summit Builders will allow us to continue to expand the organization while still providing outstanding, quality services to our clients. We are thrilled to be joining forces with a company that shares our commitment to customer satisfaction,” said Jeffrey Stone, President of Summit Builders.

About dck

dck worldwide is global construction company specializing in developing, managing, and building complex projects in several core markets, including federal/military, high-end resorts, healthcare, and corrections. Backed by 90 years of history, dck delivers high quality performance with a strong commitment to safety, resulting in exceptional projects being delivered on time and budget.

Headquartered in Pittsburgh, Pennsylvania, dck has regional offices in Hawaii, Guam, Red Oak, Omaha, Fort Lauderdale, and the Philippines and multiple project offices in the Caribbean. dck’s global footprint is continually expanding, and its family of companies includes dck north america, dck pacific construction, dck pacific guam, Oakview dck, dck philippines, dck/FWF, dck international, and now Summit dck.

For more information on dck worldwide, visit www.dckww.com.

“This property is conveniently located in the Westchase District and a location that aligns with our commitment to making our company a great place to work.”

“We searched for several months for the right site to build a headquarters campus where our employees and future employees can come together to work, and develop their skills and talents,” said Greg C. Garland, chairman and chief executive officer of Phillips 66. “This property is conveniently located in the Westchase District and a location that aligns with our commitment to making our company a great place to work.”

The company is currently working on a design for the headquarters and intends to begin construction when plans are finalized and permitting is in place. The campus will include office space, conference and training facilities, along with wellness and dining options. Once ground is broken at the new site, construction is expected to take between 24-36 months.

“Phillips 66 has chosen an excellent property, in the heart of one of the most desirable business sections in the city,” said Jim Thomas, chairman and chief executive officer of Thomas Properties Group. “Its neighbors will include many of Houston’s top companies, and the site’s proximity to major roadways makes it a prime place to do business.”

After emerging as an independent downstream company in May, Phillips 66 relocated its corporate offices from the ConocoPhillips campus in the Energy Corridor to temporary headquarters at the Pinnacle Westchase building.

About Phillips 66

Headquartered in Houston, Phillips 66 is an advantaged downstream energy company with segment-leading Refining and Marketing (R&M), Midstream and Chemicals businesses. The company has approximately 14,000 employees worldwide. The company’s R&M operations include 15 refineries with a net crude oil capacity of 2.2 million barrels per day, 10,000 branded marketing outlets, and 15,000 miles of pipeline systems. In Midstream, the company primarily conducts operations through its 50 percent interest in DCP Midstream, LLC, one of the largest natural gas gatherers and processors in the United States, with 7.2 billion cubic feet per day of gross natural gas processing capacity. Phillips 66’s Chemicals business is conducted through its 50 percent interest in Chevron Phillips Chemical Company LLC, one of the world’s top producers of olefins and polyolefins with more than 30 billion pounds of net annual chemicals processing capacity across its product lines. For more information, visit www.phillips66.com.

About Thomas Properties Group, Inc.

Thomas Properties Group, Inc., based in Los Angeles, is a full-service real estate company that owns, acquires, develops and manages primarily office, as well as mixed-use and residential properties on a nationwide basis. The company's primary areas of focus are the acquisition and ownership of premier properties, both on a consolidated basis and through its strategic joint ventures, property development and redevelopment, and property management and leasing activities. For more information about Thomas Properties Group, Inc., please visit www.tpgre.com.

Forward Looking Statements

CAUTIONARY STATEMENT FOR THE PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements made in this press release that are not historical may contain forward-looking statements. Although TPGI believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, these statements are subject to numerous risks and uncertainties. Factors that could cause actual results to differ materially from TPGI’s expectations include actual and perceived trends in various national and economic conditions that affect global and regional markets for commercial real estate services (including interest rates), the availability of credit and equity investors to finance commercial real estate transactions, our ability to enter into or renew leases at favorable rates, which can be impacted by the financial condition of our tenants, risks associated with the success of our development and property redevelopment projects, general volatility in the securities and credit markets, and the impact of tax laws affecting real estate. For a discussion of some of the factors that may cause our results to differ from management’s expectations, see the information under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K for the year ended December 31, 2011 and our subsequent Form 10-Q quarterly reports, each of which is filed with the Securities and Exchange Commission. TPGI disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50406541&lang=en

Codexis granted Mr. O’Toole an option to purchase 200,000 shares of Codexis’ common stock with an exercise price equal to $2.72, the closing price per share of common stock as reported by NASDAQ on September 10, 2012. The option will vest and become exercisable on September 4, 2013 as to 25% of the shares subject thereto, with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 months thereafter, subject to Mr. O’Toole’s continuous service with Codexis through the applicable vesting date, such that the option will be fully vested and exercisable on September 4, 2016. In addition, Codexis granted to Mr. O’Toole an award of 50,000 shares of restricted stock that will vest as to 25% of the shares subject thereto on each anniversary of September 4, 2012, subject to Mr. O’Toole’s continuous service to Codexis through the applicable vesting date, such that the Restricted Stock Award will be fully vested on September 4, 2016. Each of the option and restricted stock award is eligible for accelerated vesting under the change of control severance agreement entered into with Mr. O’Toole.

Codexis is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.

Kevin Hrusovsky, president Life Sciences and Technology, PerkinElmer, will provide perspectives on enabling a revolution in global health through personalized medicine-based technologies.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

“The addition of DSW improves the overall customer draw by adding a strong soft goods retailer to our already outstanding tenant mix”

“The addition of DSW improves the overall customer draw by adding a strong soft goods retailer to our already outstanding tenant mix,” said John Reynolds, assistant vice president/asset manager for RPAI. “We are pleased to be a part of DSW’s growth initiative,” he added.

Gateway Pavilions is a 301,775-square-foot power center located in Avondale, AZ, one of the fastest growing areas in Maricopa County. The center successfully draws customers with a great mix of retail stores and restaurants and is adjacent to Costco and Harkins Theatres with key tenants including Bed Bath & Beyond, Marshalls and Sports Authority.

DSW Inc. is a leading branded footwear and accessories retailer that offers a wide selection of brand name and designer dress, casual and athletic footwear and accessories for women, men and kids. As of August 21, 2012, DSW operated 338 stores in 41 states and operated an e-commerce site, http://www.dsw.com, and a mobile website, http://m.dsw.com. DSW also supplied footwear to 344 leased locations in the United States. For store locations and additional information about DSW, visit http://www.dswinc.com. Follow DSW on Twitter at http://twitter.com/DSWShoeLovers and "like" DSW on Facebook at http://www.facebook.com/DSW.

About RPAI

Retail Properties of America, Inc. is a fully integrated, self-administered and self-managed real estate company that owns and operates high quality, strategically located shopping centers across 35 states. The company is one of the largest owners and operators of shopping centers in the United States. The company is publicly traded on the New York Stock Exchange under the ticker symbol RPAI. Additional information about the company is available at www.rpai.com.

Forward-Looking Statements

The statements and certain other information contained in this press release, which can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “continue,” “remains,” “intend,” “aim,” “towards,” “should,” “prospects,” “could,” “future,” “potential,” “believes,” “plans,” “goal,” “initiative,” “likely,” “anticipate,” and “probable,” or the negative thereof or other variations thereon or comparable terminology, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. These statements should be considered as subject to the many risks and uncertainties that exist in the Company’s operations and business environment. Such risks and uncertainties could cause actual results to differ materially from those projected. These uncertainties include, but are not limited to, that the closing of the aforementioned offering is subject to, among other things, standard closing conditions and customary rights of the underwriters to terminate the underwriting agreement due to any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company does not undertake any duty to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

“In addition, we maintain comprehensive and transparent global data privacy policies and perform annual, third-party security testing to validate that we’re ahead of the curve and investing in the most relevant technologies available.”

“Our involvement in the IAPP allows us to actively monitor the evolving data privacy landscape and develop industry-leading solutions that ensure the data our customers entrust to us is highly protected,” said Omar Amlani, Vice President of IT Operations. “In addition, we maintain comprehensive and transparent global data privacy policies and perform annual, third-party security testing to validate that we’re ahead of the curve and investing in the most relevant technologies available.”

AlertDriving’s data centers are strategically located to comply with the most stringent cross-border data privacy and transfer laws, including the EU Data Protection Directive.

Established in 1998, AlertDriving pioneered web-based driver risk management and has trained over 1,000,000 drivers worldwide, providing driver safety training to more countries and in more languages than anyone in the world. The company’s fully customizable, driver risk management platform, called FleetDefense^SM, has helped clients significantly reduce their collisions, injuries, costs and liability exposure.

Festival Miami opens with Leon Fleisher conducting the Frost Symphony Orchestra in a stimulating program, featuring music by Beethoven and Rachmaninoff. The Frost Wind Ensemble performs works by Paul Hindemith, Jennifer Higdon, and Paul Dooley and will feature Frost percussion faculty Svet Stoyanov as soloist. Pianist Santiago Rodriguez returns by popular demand to present a solo recital; Grammy Award-winning soprano Ana María Martínez will perform a concert of enduring songs and arias, and Karen Kennedy conducts a massive ensemble comprised of the Master Chorale of South Florida and over 200 choral and orchestra students from the Frost School of Music in Carl Orff’s thrilling Carmina Burana. Florida’s Singing Sons Boychoir will present a children’s concert in collaboration with Sunday Afternoons of Music.

Festival Miami presents award-winning jazz headliners Dave Liebman, Jason Moran, and Roseanna Vitro in the newly renovated UM Maurice Gusman Concert Hall and co-presents George Benson, Freddy Cole with the Frost School’s Henry Mancini Institute Orchestra as they perform Unforgettable: A Tribute to Nat King Cole in collaboration with Larry Rosen’s Jazz Roots series at the Adrienne Arsht Center.

Festival Miami then features Broadway vocal sensations Michael Maguire (Les Miserables) and Valerie Perri Lipson (Evita) in an entertaining Best of Broadway concert. The festival rounds out its ambitious programming with Latin fusion artists Carlos Oliva y Los Sobrinos del Juez, the incredible vocalist Jon Secada, Brazilian jazz virtuosos Trio da Paz, and presents a set of two tango concerts in tribute to composer and bandoneónist Astor Piazzolla.

For ticket information call 305-284-4940 or visit www.festivalmiami.com. Other artists to be announced. All artists are subject to change without notice; check website for updates.

Festival Miami concerts are presented at the Maurice Gusman Concert Hall and Clarke Recital Hall on the UM Gables campus, and at the Adrienne Arsht Center in downtown Miami.

Die Telefonkonferenz wird um 15:00 Uhr MESZ – 9:00 Uhr EDT beginnen. Eine Pressemitteilung zu den Ergebnissen wird am gleichen Tag vor der Telefonkonferenz veröffentlicht.

Um Zugang zu der Telefonkonferenz zu erhalten, wenden Sie sich bitte etwa 10 Minuten vor Beginn der Konferenz an den Betreiber der Telefonkonferenz unter +1-800-230-1059 innerhalb Nordamerikas beziehungsweise +1-612-234-9959 außerhalb Nordamerikas und fragen Sie nach dem „Schlumberger Earnings Conference Call“.

Gleichzeitig zur Telefonkonferenz steht Ihnen unter www.slb.com/irwebcast ein Webcast zum Mithören zur Verfügung. Zuhörer sollten sich 15 Minuten vor Beginn der Konferenz anmelden, um ihren Browser zu testen und sich für den Webcast zu registrieren. Nach Ende der Telefonkonferenz wird eine Aufnahme bis zum 19. November 2012 unter www.slb.com/irwebcast zur Verfügung stehen. Der Zugang erfolgt über die Nummer +1-800-475-6701 innerhalb Nordamerikas beziehungsweise +1-320-365-3844 außerhalb Nordamerikas unter Angabe des Zugangscodes 255344.

Über Schlumberger

Schlumberger ist der weltweit führende Anbieter von Lösungen in den Bereichen Technologie, integriertes Projektmanagement und Daten für Kunden aus der Erdöl- und Erdgasindustrie auf der ganzen Welt. Mit etwa 115.000 Mitarbeitern, die über 140 verschiedene Nationalitäten umfassen und in rund 85 Ländern tätig sind, bietet Schlumberger die branchenweit größte Auswahl an Produkten und Dienstleistungen von der Exploration bis hin zur Förderung.

Schlumberger Limited hat seine Hauptgeschäftsstellen in Paris, Houston und Den Haag und hat 2011 einen Umsatz aus laufender Geschäftstätigkeit in Höhe von 36,96 Milliarden US-Dollar ausgewiesen. Weitere Informationen finden Sie unter www.slb.com.

Die Ausgangssprache, in der der Originaltext veröffentlicht wird, ist die offizielle und autorisierte Version. Übersetzungen werden zur besseren Verständigung mitgeliefert. Nur die Sprachversion, die im Original veröffentlicht wurde, ist rechtsgültig. Gleichen Sie deshalb Übersetzungen mit der originalen Sprachversion der Veröffentlichung ab.

La teleconferenza avrà inizio alle ore 9:00 del fuso orario della costa orientale degli Stati Uniti, ovvero alle ore 15:00 del fuso orario di Parigi. Lo stesso giorno, prima della teleconferenza, verrà rilasciato un comunicato stampa sui risultati in oggetto.

Coloro che desiderano partecipare alla teleconferenza sono invitati a contattare l’operatore addetto, al numero +1-800-230-1059 per chi chiama dal Nord America o al numero +1-612-234-9959 per chi chiama da altri Paesi, circa 10 minuti prima dell’inizio dell'evento, chiedendo della “Teleconferenza sugli utili di Schlumberger”.

Un webcast della teleconferenza sarà trasmesso simultaneamente all’indirizzowww.slb.com/irwebcast esclusivamente in formato audio.

Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua originale, che è l'unico giuridicamente valido.

La téléconférence est prévue à 15 h 00 (heure de Paris), soit 9 h 00, heure de New York. Un communiqué de presse relatif aux résultats sera publié le même jour avant l'appel.

Pour accéder à la téléconférence, les auditeurs doivent contacter l'opérateur de cette dernière en composant le +1-800-230-1059 en Amérique du Nord ou le +1-612-234-9959 hors Amérique du Nord, environ 10 minutes avant le début de l'appel, et mentionner « Schlumberger Earnings Conference Call ».

Une émission Web de la téléconférence sera diffusée simultanément à l'adresse www.slb.com/irwebcast en mode audio uniquement. Les auditeurs devront se connecter 15 minutes avant le début de l'appel afin de tester leurs navigateurs et de s’inscrire pour l’émission Web. À la fin de la téléconférence, une rediffusion restera disponible à l'adresse www.slb.com/irwebcast jusqu'au 19 novembre 2012. Pour y accéder, veuillez composer le +1-800-475-6701 en Amérique du Nord ou le +1-320-365-3844 hors Amérique du Nord et fournir le code d'accès 255344.

À propos de Schlumberger

Schlumberger est le plus grand fournisseur au monde de solutions de technologie, de gestion de projet intégrée et d’information à des clients internationaux qui exercent leurs activités dans l’industrie du gaz et du pétrole. Avec près de 115 000 employés représentant plus de 140 nationalités et travaillant dans près de 85 pays, Schlumberger fournit la gamme la plus vaste de produits et services du secteur, de l’exploration à la production.

Schlumberger Limited, dont les bureaux principaux sont situés à Paris, à Houston et à La Haye, a déclaré un chiffre d’affaires de 36,96 milliards USD en 2011. Pour de plus amples renseignements, veuillez consulter le site www.slb.com.

Le texte du communiqué issu d’une traduction ne doit d’aucune manière être considéré comme officiel. La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.

“We are working hard to help shop owners be as successful as possible”

“Our shop owners on Ruby Lane have requested, through open suggestions and our Annual Satisfaction Survey, for an alternative payment system on the site. We have listened,” said Palmer Pekarek, Director of Communications and New Business Development at RubyLane.com.

“Through extensive research, we discovered that Amazon Payments was a great additional selling tool for our shop owners. It was a simple choice once the research was completed - more buyers than any other online payment system are poised to shop using their existing Amazon accounts,” said Pekarek.

So, not only do buyers benefit from additional purchase options, but sellers do as well.

“We were able to work with the Amazon Team and secure a special introductory rate for our current and future shop owners,” said Pekarek.

With this special introductory offer, sellers on the site only pay 2.4% plus $0.30 per transaction (regardless of the sales volume through Amazon Payments), rather than the usual rate of 2.9% plus $0.30 per transaction, until at least October 1, 2013. After the introductory period, rates are subject to change, but will not exceed 2.9% plus $0.30 per transaction (for International Orders there is an additional 1% fee per transaction). “For many, that is a half-percent savings per transaction for an entire year, and cost savings always help the bottom-line,” says Pekarek.

Ruby Lane also announced, that though October 31, 2012, the site is waiving its $75 set-up fee for new shops wanting to sell on the site. “We are working hard to help shop owners be as successful as possible,” says Pekarek. “Helping drive customers to their shops with new features, payment systems and our outstanding reputation is part of what makes shopping and selling on Ruby Lane a great experience.”

If you have not taken a look at online vintage, antiques and collectibles king Ruby Lane, stop by for a visit at www.RubyLane.com.

About Ruby Lane

Since 1998, Ruby Lane has brought together individually-owned shops offering unique items from around the world. Today, the online King of Vintage Collectibles, Ruby Lane, offers more than 448,000 items in inventory ranging from antique furniture to depression glass, fine china, vintage jewelry, heirloom linens, books, stamps, paintings, sculpture, hand-blown glass, and ceramics from more than 2,500 shops. Visit www.RubyLane.com.

Forest intends to use a portion of the net proceeds from the offering of approximately $490.2 million (after deducting the initial purchasers’ discount and estimated expenses) to fund the proposed redemption of 50% of the aggregate principal amount of its outstanding 8.5% Senior Notes due 2014 (the “2014 Notes”), and the balance to reduce borrowings under its bank credit facility. The principal amount outstanding of the 2014 Notes is $600 million. Pending the proposed redemption of the 2014 notes, the portion of the net proceeds necessary to fund that redemption will be used to temporarily reduce borrowings under Forest’s bank credit facility or for general corporate purposes.

The Senior Notes will be offered only to persons reasonably believed to be qualified institutional buyers in reliance upon Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons in transactions outside the United States in reliance upon Regulation S under the Securities Act.

The Senior Notes have not been registered under the Securities Act or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and applicable state securities laws. This press release is being issued pursuant to Rule 135c under the Securities Act, and does not and shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which the offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. This press release does not and shall not constitute a notice of redemption of the 2014 Notes. Such notice will be given to holders of the 2014 Notes in the manner prescribed in the indenture governing the 2014 Notes and at the appropriate time.

FORWARD-LOOKING STATEMENTS

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, that address activities that Forest intends, assumes, plans, expects, believes, projects, estimates, or anticipates (and other similar expressions) will, should, or may occur in the future are forward-looking statements. The forward-looking statements provided in this press release are based on management's current belief, based on currently available information, as to the outcome and timing of future events. Forest cautions that future natural gas and liquids production, revenues, cash flows, liquidity, plans for future operations, expenses, outlook for oil and natural gas prices, timing of capital expenditures, and other forward-looking statements relating to Forest are subject to all of the risks and uncertainties normally incident to their exploration for and development and production and sale of liquids and natural gas.

These risks relating to Forest include, but are not limited to, oil and natural gas price volatility, its level of indebtedness, its ability to replace production, its ability to compete with larger producers, environmental risks, drilling and other operating risks, regulatory changes, credit risk of financial counterparties, risks of using third-party transportation and processing facilities and other risks as described in reports that Forest files with the SEC, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Any of these factors could cause Forest's actual results and plans to differ materially from those in the forward-looking statements.

Forest Oil Corporation is engaged in the acquisition, exploration, development, and production of natural gas and liquids in the United States and selected international locations. Forest's principal reserves and producing properties are located in the United States in Arkansas, Louisiana, Oklahoma, Texas, Utah, and Wyoming. Forest's common stock trades on the New York Stock Exchange under the symbol FST. For more information about Forest, please visit its website at www.forestoil.com.

“Gaurav tem um histórico bem estabelecido na instalação e direção de operações comerciais bem sucedidas na Ásia e no Oriente Médio, assim como na gestão da distribuição global”

O Sr. Garg se junta a Mercer proveniente da Chartis, o braço de seguros P&C da American International Group, Inc. (AIG), onde, recentemente, ocupava os cargos de Diretor-Presidente e Diretor Administrativo da Tata AIG General Insurance Company Ltd., na Índia. Ele entrou para a AIG em 2000 e ocupou uma série de cargos de liderança, inclusive cargos no país, regionais e globais, com um forte foco internacional.

"Gaurav tem um histórico bem estabelecido na instalação e direção de operações comerciais bem sucedidas na Ásia e no Oriente Médio, assim como na gestão da distribuição global", disse o Sr. Portalatin. "Sua forte capacidade empreendedora e a profunda compreensão da dinâmica dos mercados com crescimento serão inestimáveis para orientar a expansão lucrativa de receitas para a Mercer nestes países. Nossa decisão de nomeá-lo para este novo cargo crítico na Mercer é a prova de nosso compromisso em investir e maximizar nossas oportunidades nos mercados com crescimento.”

O Sr. Garg traz 26 anos de experiência internacional para seu cargo na Mercer. De 2004 a 2007, o Sr. Garg trabalhou em Nova York na American International Underwriters (AIU), onde era responsável pela contratação de seguros e P&L em seis regiões (Europa, CE/CIS, Mediterrâneo, Oriente Médio e Ásia-Pacífico, China e Australásia) e era responsável pela distribuição global das linhas de negócios de seguros pessoais da AIU. Ele também foi responsável pelas operações da empresa start-up da AIU em vários países na Ásia e no Oriente Médio, e sua experiência inclui o trabalho em três países do BRIC – Índia, Rússia e China. Ele foi fundamental no lançamento da Tata AIG em 2000, e, após isso, ele assumiu um cargo regional em 2002, supervisionando o Oriente Médio e o Sul da Ásia, antes de passar para o cargo da linha de negócios globais em Nova York em 2004. Ele se tornou Diretor-Presidente e Diretor Administrativo da AIG Insurance Joint Venture na Índia com o Tata Group em 2007. Ele começou sua carreira em 1986 na National Insurance Co. Ltd., onde administrou diversas carteiras, desde seguros de varejo a seguros de grandes projetos de engenharia.

O Sr. Garg possui diploma de bacharel em Comércio e diploma de mestrado em Administração de Empresas. É aluno do Wharton Advanced Management Program (Programa de Gerenciamento Avançado Wharton). Ele também é membro do Instituto de Seguros da Índia e Membro do Chartered Insurance Institute, Reino Unido.

Sobre a Mercer

A Mercer é uma empresa líder global de consultoria em talento, saúde, aposentadoria e investimentos. A Mercer ajuda clientes no mundo todo a promover a saúde, a riqueza e o desempenho de seu bem mais importante – seu pessoal. Os 20.000 funcionários da Mercer estão localizados em mais de 40 países. A Mercer é uma subsidiária integral da Marsh & McLennan Companies (NYSE: MMC), uma equipe global de empresas de serviços profissionais, que oferece aos clientes assessoria e soluções nas áreas de risco, estratégia e capital humano. Com 52.000 funcionários em todo o mundo e receita anual superior a US$10 bilhões, a Marsh & McLennan Companies também é a empresa controladora da Marsh, que é líder mundial em gerenciamento de riscos e corretagem de seguro; Guy Carpenter, líder global no fornecimento de serviços intermediários de resseguros e riscos; e Oliver Wyman, uma líder global em consultoria administrativa. Para obter outras informações, acesse www.mercer.com. Siga a Mercer no Twitter @MercerInsights.

O texto no idioma original deste anúncio é a versão oficial autorizada. As traduções são fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que é a única versão do texto que tem efeito legal.

CCA has accepted for payment 977 ARPS, which represents approximately 99.9% of its outstanding ARPS, and one (1) Municipal Auction Rate Cumulative Preferred Share remains outstanding.

CXE has accepted for payment 3,675 ARPS, which represents approximately 94.2% of its outstanding ARPS, and 225 ARPS remain outstanding.

MFM has accepted for payment 4,259 ARPS, which represents approximately 93.6% of its outstanding ARPS, and 291 ARPS remain outstanding.

In addition, MFS® High Yield Municipal Trust (NYSE: CMU) and MFS® Investment Grade Municipal Trust (NYSE: CXH) each announced that all conditions to the closing of its cash tender offer to purchase up to 100% of its outstanding ARPS have been satisfied. CMU accepted for payment 2,844 ARPS, which represents approximately 94.8% of its outstanding ARPS, and 156 ARPS remain outstanding. CXH accepted for payment 1,917 ARPS, which represents approximately 98.3% of its outstanding ARPS, and 33 ARPS remain outstanding.

The ARPS of each fund that were not tendered remain outstanding. Pursuant to approval by ARPS holders, each fund's bylaws have been amended to replace Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. ("S&P"), with Fitch, Inc. ("Fitch"), as a ratings agency for each fund's ARPS and make other noted changes as described in the funds' Notice of Special Meeting and Proxy Statement dated August 9, 2012. Otherwise, the terms of the outstanding ARPS remain the same.

Stockholders who have questions about the tender offers should contact their financial advisor or call Warren Antler of AST Fund Solutions, Inc., each fund’s information agent for its tender offer, at 212-400-2605.

Each fund offered to purchase its outstanding ARPS at a price per share equal to 95% of the ARPS' per share liquidation preference of $25,000 ($23,750 per share) plus any unpaid dividends accrued through the expiration date of the tender offer.

MFS Investment Management® (MFS®) manages $293.4 billion in assets as of August 31, 2012. The company traces its origins to 1924 and the creation of America's first mutual fund.

This release is not a prospectus, circular or representation intended for use in the purchase or sale of fund shares. Shares of the funds are not FDIC-insured and are not deposits or other obligations of, or guaranteed by, any bank. Shares of the funds involve investment risk, including possible loss of principal. For more complete information about each fund, including risks, charges, and expenses, please see the fund’s annual and semi annual shareholder report.

The funds are closed-end funds. Common shares of the funds are only available for purchase/sale on the NYSE at the current market price, except MFS California Municipal Fund, which is available for purchase/sale on the NYSE/AMEX at the current market price. Common shares may trade at a discount to NAV.

MFS Investment Management
500 Boylston St., Boston, MA 02116

26098.1

„Bei Quintiles geht es wirklich um Teamleistung, und in einer grenzenlosen Welt lenkt dieser Preis die Aufmerksamkeit darauf, dass wir gemeinsam mit unseren Hauptkunden etwas ganz Besonderes schaffen konnten, was tiefgreifende Auswirkungen auf die zukünftig klinische Forschung haben wird.“

InformationWeek ermittelt und ehrt die innovativsten Nutzer von Informationstechnologien des Landes mit seiner jährlichen Liste der Top 500 und dokumentiert außerdem die Technologien, Strategien, Investitionen und Verwaltungspraktiken der bekanntesten US-amerikanischen Unternehmen. Die Liste wirft ein Schlaglicht auf die Kraft der Innovation in der Informationstechnologie, anstatt nur die Firmen mit den größten Ausgaben im IT-Bereich zu ermitteln.

Der treibende Faktor bei der diesjährigen InformationWeek-500-Rangliste war die Zusammenarbeit von Quintiles mit Eli Lilly an einem IT-fähigen Projekt zur Neugestaltung der Art und Weise, wie klinische Studien geplant und konzipiert werden. Das endgültige Ziel dieser Zusammenarbeit lag darin, einen integrierten Ansatz zu entwickeln, der kostenaufwändige Ineffizienzen unnötig macht und sich große Datenmengen zunutze macht, um bei der Entwicklung von Medikamenten bessere Entscheidungen begünstigen zu können.

Jeff Kasher, Vize President für globale klinische Entwicklung bei Eli Lilly, sagt, dass die Zusammenarbeit mit Quintiles zu einer Lösung geführt habe, die sich auf die Fähigkeit von Lilly zur Durchführung klinischer Studien positiv ausgewirkt hat. „Zur Maximierung des Erfolgs wurden grundlegende, radikale Veränderungen angeregt, da wir wussten, dass schrittweise Veränderungen nicht ausreichen würden. Ich kann mir nicht vorstellen, dass ein anderer Partner als Quintiles dies realisiert haben könnte.“

Der Chief Information Officer von Quintiles, Richard Thomas, sagt, dass sein Team sehr stolz darauf sei, als einer der branchenübergreifend führenden technischen Innovatoren gewürdigt zu werden. „Bei Quintiles geht es wirklich um Teamleistung, und in einer grenzenlosen Welt lenkt dieser Preis die Aufmerksamkeit darauf, dass wir gemeinsam mit unseren Hauptkunden etwas ganz Besonderes schaffen konnten, was tiefgreifende Auswirkungen auf die zukünftig klinische Forschung haben wird.“

„Wenn wir nach vorne blicken, sehen wir, dass die von uns bediente Gesundheitsbranche noch zahlreiche, nicht unerhebliche Probleme zu lösen hat“, so Thomas weiter. „Der Erhalt dieses Preises erhöht unsere Schwungkraft und betont die entscheidende und immer dringlichere Bedeutung der Arbeit, die wir bei Quintiles tun.“

„Mit den InformationWeek 500 sind die innovativsten Nutzer von Unternehmenstechnologien der letzten 24 Jahre gewürdigt worden, und die Innovationen dieses Jahres waren besonders eindrucksvoll“, sagte der Chefredakteur von InformationWeek, Rob Preston. „Die Herausgeber haben nach unkonventionellen Ansätzen gesucht – neue Technologien, neue Modelle, neue Arten, Geschäftschancen zu ergreifen und komplexe Geschäftsprobleme mit IT zu lösen.“

Weitere Details zu den InformationWeek 500 finden Sie online unter http://www.informationweek.com/1343.

Über das InformationWeek Business Technology Network

Das InformationWeek Business Technology Network bietet IT-Führungskräften einzigartige Analysen und Werkzeuge, passend zu ihrem Workflow – von der Festlegung und Formulierung von Zielsetzungen bis hin zur Überprüfung und dem Empfehlen von Lösungen. Das Netzwerk ist verankert in InformationWeek, dem Top-Multimediaanbieter mit Überblick über das gesamte Unternehmen, und umfasst die entscheidendsten technischen Kategorien mit Online-Institutionen wie DarkReading.com (Sicherheit), NetworkComputing.com (Networking und Kommunikation) und PlugintotheCloud.com (Cloud-Computing).

Über Quintiles

Quintiles ist das einzige voll integrierte Unternehmen für biopharmazeutische Dienstleistungen, das weltweit klinische, kaufmännische, beratende und kapitalbezogene Lösungen anbietet. Unser Netzwerk von mehr als 25.000 Mitarbeitern in 60 Ländern hat einen Blick für die Zukunft und liefert dabei schon heute Ergebnisse mit unerschütterlichem Einsatz für Patienten, Sicherheit und Ethik. Quintiles unterstützt biopharmazeutische Unternehmen bei der Entwicklung und Vermarktung von Produkten zur Verbesserung und Verlängerung des Lebens von Patienten und beweist damit seinen Wert bei den Interessengruppen. Weitere Informationen finden Sie unter www.quintiles.com. Zusätzliche Neuigkeiten über das Unternehmen finden Sie unter www.quintiles.com/news.

Klicken Sie hier, um mobile Benachrichtigungen von Quintiles zu abonnieren.

Die Ausgangssprache, in der der Originaltext veröffentlicht wird, ist die offizielle und autorisierte Version. Übersetzungen werden zur besseren Verständigung mitgeliefert. Nur die Sprachversion, die im Original veröffentlicht wurde, ist rechtsgültig. Gleichen Sie deshalb Übersetzungen mit der originalen Sprachversion der Veröffentlichung ab.

Fitch Ratings has published updated recovery analyses for the following U.S. gaming operators:

--Caesars Entertainment Operating Co. (including Chester Downs and Marina LLC)

--Caesars Linq, LLC & Caesars Octavius, LLC

--MGM Resorts International

--CityCenter Holdings, LLC

--Boyd Gaming Corporation

--Marina District Finance Company, Inc (Borgata)

--Peninsula Gaming, LLC (Newly assigned IDR and Security Specific Ratings)

--Pinnacle Entertainment, Inc.

Effective Aug. 10, 2012, Fitch Ratings updated its Ratings Definitions, expanding the application of '+/-' to corporate issue ratings at the 'CCC' level and defining a rating action as 'Under Review'. The '+/-' designations at the 'CCC' level are limited to instrument ratings and will not be used for Issuer Default Ratings, leaving 'CCC' as the sole issuer rating within the 'CCC' category. The new designations provide greater comparability to debt instruments and Recovery Ratings in the lower end of the speculative-grade rating scale, and are not intended to reflect any change in Fitch's view of the creditworthiness of the issuers or instruments changed in this rating action.

Gaming companies with issue and Recovery Ratings affected by the change in the scale include MGM Resorts International, Boyd Gaming Corporation, and Peninsula Gaming, LLC.

Certain gaming companies' ratings were also affected by the change in rating criteria, but had been publicly updated prior to this rating action commentary, including Caesars Entertainment Operating Co., Caesars Linq, LLC and Caesars Octavius, LLC.

The interactive recovery analysis worksheets are available at 'www.fitchratings.com' under the following headers:

Sectors >> Corporate Finance >> Corporates >> Research

Additional information is available at 'www.fitchratings.com'.

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE.

The report is available at 'www.fitchratings.com'.

Additional information is available at 'www.fitchratings.com'.

Applicable Criteria and Related Research: Culpeper County, Virginia

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=687599

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE.

“The company is accused of misleading shareholders by failing to disclose known facts regarding counterfeit versions of its airMax wireless gear being sold by Kozumi USA Corp.”

“The company is accused of misleading shareholders by failing to disclose known facts regarding counterfeit versions of its airMax wireless gear being sold by Kozumi USA Corp.,” securities lawyer Hamilton Lindley said. “As a result, stocks traded at artificially inflated prices. Our proposed shareholder lawsuit will seek to ensure that proper controls are placed to correct any improper behavior, and to improve the company’s value for investors.”

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Ubiquiti Networks shareholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855.

New World Online Charter complies with all Arizona graduation requirements and offers a comprehensive, standards-based high school curriculum, including Advanced Placement courses and a wide variety of electives. Students complete their coursework from the comfort of their own homes and have online access to experienced, Arizona-certified teachers who can provide real-time instruction 24 hours a day. If additional assistance is needed, students can meet with highly qualified teachers in person at New World Educational Center’s downtown facility.

New World students can jump-start their college careers with early graduation options and two programs offering dual enrollment in online college classes offered by DeVry University. The Passport to College program lets any eligible student take up to two career-focused DeVry classes online free of charge, while the Dual Credit program allows students to take freshman-level math and English classes and receive both high school and college credit.

NWOC is ideal for many students, including home-schooled students, those needing a flexible schedule due to work or outside activity or family obligations, students living in remote locations, advanced learners, or students with health or physical challenges. Nationally recognized learning provider Advanced Academics supplies the program’s learning management system, web-based curriculum and online teaching staff.

New World Online Charter is still enrolling new students for the 2102-13 school year. For more information, go to www.NewWorldOnlineCharter.org or call 602-337-8842.

About New World Online Charter

New World Online Charter is a program of New World Educational Center, a public charter school that has provided Phoenix children with a quality educational option since 1976.

“This trial represents the most comprehensive experience for any treatment option for atrial fibrillation, and we’re looking forward to this significant study designed to treat patients with this life-threatening condition.”

The initial FDA approval study, ABLATE, reported 84 percent of patients free from AF at six months following Maze IV treatment and 75 percent of patients free of AF at a mean follow-up of 22 months when assessed by 48-hour Holter monitors. The Maze IV procedure is normally performed at the time of a primary open heart procedure where access to the heart is routinely established.

The ABLATE and PAS studies focus on the most difficult to treat, chronic forms of AF known clinically as “non-paroxysmal AF.” The chronic AF patient group represents roughly half of the diagnosed patient population and has been extremely challenging to manage with conventional medical therapy or catheter ablation.

According to Patrick McCarthy, MD,* Director of the Bluhm Cardiovascular Institute at Northwestern University Feinberg School of Medicine and Chair of the PAS Executive Committee, “The ABLATE Post Approval Study represents an important study which will provide the evidence to validate the treatment of these underserved patients with intractable forms of AF,” he says. “This trial represents the most comprehensive experience for any treatment option for atrial fibrillation, and we’re looking forward to this significant study designed to treat patients with this life-threatening condition.”

The company’s founder, Michael Hooven, is optimistic about the FDA approval and the PAS. “Receiving the first and only FDA approval for the surgical treatment of Atrial Fibrillation was a major milestone for AtriCure. We are now able to fulfill our mission of improving patient outcomes by offering a standardized surgeon training program focused on the Maze IV procedure. Our data suggests that currently only 3 in 10 cardiac surgery patients with an AF diagnosis receive an AF procedure and only 1 in 10 receive a complete Maze IV procedure. We expect the PAS study will provide additional compelling evidence of the benefits of the AtriCure Maze IV procedure and be a catalyst for making it the standard of care."

Concurrently with the post-approval study, AtriCure is sponsoring an extensive Maze IV training program for cardiovascular surgeons. This course was developed by recognized leaders in the field of surgical ablation and is recognized by the Society of Thoracic Surgeons as an Endorsed Industry Education Program. For more information about this course, visit targetaf.com.

About AtriCure, Inc.

AtriCure, Inc. is a leader in medical device development, manufacturing and sales of innovative cardiac surgical ablation systems designed for the treatment of AF and for the exclusion of the left atrial appendage. AF affects more than 2 million people in the United States and is responsible for 15 percent of strokes. It is estimated that by 2050 more than 12 million individuals will have a form of AF. For more information regarding AtriCure, visit www.atricure.com

The FDA has not cleared or approved certain AtriCure products for the treatment of AF or a reduction in the risk of stroke.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates, other predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure’s products. Forward-looking statements are based on AtriCure’s experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure’s control. These risks and uncertainties include the rate and degree of market acceptance of AtriCure’s products, AtriCure’s ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of and ability to obtain reimbursement of procedures utilizing AtriCure’s products, competition from existing and new products and procedures or AtriCure’s ability to effectively react to other risks and uncertainties described from time to time in AtriCure’s SEC filings, such as fluctuation of quarterly financial results, reliance on third party manufacturers and suppliers, litigation or other proceedings, government regulation and stock price volatility. AtriCure does not guarantee any forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

*Dr. McCarthy has been reimbursed by AtriCure for limited travel and related expenses related to his involvement in the ABLATE AF PAS clinical trial. MKT-1639A-G

« Pour nous donner les meilleures chances de succès, nous avons œuvré dans le sens d'un changement perturbateur complet, conscients qu'un changement progressif ne serait pas suffisant. Je ne peux imaginer aucun autre partenaire que Quintiles capable de faire de ce projet une réalité »

InformationWeek identifie et récompense les utilisateurs de technologies de l'information les plus innovants de la nation, grâce à sa liste annuelle de 500 élus et suit également les pratiques des sociétés les plus connues d'Amérique en matière de technologie, de stratégie, d'investissement et d'administration. La liste met en vedette le pouvoir d'innovation en technologie de l'information, plutôt que de se contenter d'identifier les plus gros dépensiers en TI.

Le facteur décisif dans le classement InformationWeek 500 de cette année a été la collaboration de Quintiles avec Eli Lilly sur un projet adapté aux technologies de l'information destiné à reconfigurer le mode de planification et de conception des essais cliniques. L'objectif final de cette collaboration était de mettre au point une approche intégrée qui élimine les incompétences onéreuses et d'utiliser des « données volumineuses » pour mieux orienter les décisions de développement des médicaments.

Jeff Kasher, vice-président chargé du développement clinique mondial chez Eli Lilly, affirme que la collaboration avec Quintiles a débouché sur une solution qui a eu un impact positif sur la capacité de Lilly à mener des essais cliniques. « Pour nous donner les meilleures chances de succès, nous avons œuvré dans le sens d'un changement perturbateur complet, conscients qu'un changement progressif ne serait pas suffisant. Je ne peux imaginer aucun autre partenaire que Quintiles capable de faire de ce projet une réalité ».

Le directeur de l'information chez Quintiles, Richard Thomas, affirme que son équipe est très fière d'avoir été distinguée comme l'un des plus grands innovateurs technologiques tous secteurs industriels confondus. « Il s'agit véritablement d'un effort d'équipe chez Quintiles, et dans un monde sans frontières, ce prix souligne que nous avons été capables de créer quelque chose de très particulier en collaboration avec l'un de nos principaux clients et qui aura dorénavant un effet profond sur la recherche clinique.

« Si l'on regarde vers l'avenir, l'industrie des soins de santé que nous servons présente de nombreux et formidables défis à relever », a poursuivit M. Thomas. « Recevoir ce prix augmente notre élan, en renforçant la nature critique et chaque jour plus urgente du travail que nous réalisons chez Quintiles ».

« L'InformationWeek 500 a distingué les utilisateurs les plus innovants de la technologie d'entreprise pendant 24 ans et les innovations de cette année ont été particulièrement impressionnantes », a déclaré le rédacteur en chef d'InformationWeek, Rob Preston. « Ce que les rédacteurs recherchaient, c'était des approches non conventionnelles - de nouvelles technologies, de nouveaux modèles, de nouvelles manières de saisir des opportunités d'affaires et de résoudre des problèmes d'entreprise complexes grâce aux technologies de l'information ».

Des détails supplémentaires sur l'InformationWeek 500 sont disponibles en ligne sur le site http://www.informationweek.com/1343.

À propos d'InformationWeek Business Technology Network

L'InformationWeek Business Technology Network propose aux dirigeants des technologies de l'information une analyse et des outils uniques en parallèle de leur flux de travail - depuis la définition et l'élaboration des objectifs jusqu'à l'évaluation et la recommandation de solutions. Concrétisé par InformationWeek, la locomotive multimédia qui a une vue d'ensemble de l'entreprise, le réseau évolue à travers les catégories technologiques les plus critiques avec des propriétés en ligne telles que DarkReading.com (sécurité), NetworkComputing.com (réseautage et communications) et PlugintotheCloud.com (infonuagique).

À propos de Quintiles

Quintiles est le seul fournisseur de services biopharmaceutiques entièrement intégrés à proposer des solutions cliniques, commerciales, de conseil et de fonds propres à travers le monde. Son réseau de plus de 25 000 professionnels déployés dans 60 pays est orienté vers l’avenir tout en produisant des résultats aujourd’hui grâce à un engagement inébranlable envers les patients, l’innocuité des traitements et le respect de l’éthique. Quintiles aide les sociétés biopharmaceutiques à développer et commercialiser des produits qui améliorent et prolongent la vie des patients tout en démontrant leur valeur aux parties prenantes. Consultez le site www.quintiles.com pour de plus amples renseignements et le site www.quintiles.com/news pour d’autres informations sur la société.

Cliquez ici pour vous abonner aux alertes sur mobile de Quintiles.

Le texte du communiqué issu d’une traduction ne doit d’aucune manière être considéré comme officiel. La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.

„Die Ergebnisse unserer eSCOPE-Studie zeigen, dass VenaSeal eine patientenfreundliche Behandlungsoption bietet“

Laut Sapheon waren zum Behandlungszeitraum alle Eingriffe erfolgreich, mit einer Verschlussrate von 100 % nach Ultraschallkriterien. Bisher sind 60 Patienten/-innen nach 30 Tagen und 26 Patienten/-innen nach 90 Tagen zu einer Nachsorgeuntersuchung erschienen, bei einer Verschlussrate von 100 % bzw. 96 %. Im Verlauf der Studie sind keine ernsthaften Nebenwirkungen berichtet worden. Diese Ergebnisse decken sich mit der von Sapheon diesen Sommer gemeldeten einjährigen Machbarkeitsstudie mit 38 Patienten/-innen.

Der eSCOPE-Prüfarzt Dr. Jens Alm vom Dermatologikum Hamburg sagte dazu: „Mein Eindruck ist, dass die Lebensqualität von Patientinnen und Patienten nach dem VenaSeal-Eingriff im Vergleich zur Thermalablation bei Gefäßen höher ist. Meine Patienten/-innen hatten nach dem Eingriff keine Unannehmlichkeiten und brauchten keine unbequemen Kompressionsstrümpfe. Sie konnten ihre normalen Alltagsaktivitäten sofort wieder aufnehmen.”

„Die Ergebnisse unserer eSCOPE-Studie zeigen, dass VenaSeal eine patientenfreundliche Behandlungsoption bietet”, sagte Rod Raabe, M.D., Vorstand und Chief Medical Officer bei Sapheon. „Das VenaSeal-Sapheon-Verschlusssystem ist eindeutig eine effektive Behandlungsmethode, mit der die enormen Schmerzen, die Tumeszenzbetäubung, die Kompressionsstrümpfe und die ausgedehnte Genesungszeit, die mit Ablationstherapien verbunden sind, entfallen. Wir freuen uns jetzt darauf, Ärztinnen und Ärzten diese verbesserte Methode für die Behandlung von Patientinnen und Patienten anbieten zu können, die an einer verbreiteten Erkrankung leiden, welche schmerzhafte Krampfadern und unschöne Beinen zur Folge haben kann.”

Über Sapheon

Sapheon ist ein Privatunternehmen im Bereich medizinischer Geräte, dessen Zielsetzung es ist, neue Methoden für die Behandlung von Gefäßkrankheiten zu entwickeln. Das Unternehmen konzentriert sich momentan auf eine fortschrittliche Behandlungsmöglichkeit von (Stamm-)Veneninsuffizienz, einem Markt mit einem weltweiten Volumen von einer Milliarde US-Dollar. Sapheon hat für das Verschlusssystem VenaSeal™ Sapheon® die EU-Zulassung erhalten. Das Verschlusssystem VenaSeal™ von Sapheon ist in den USA derzeit nicht im Handel erhältlich. Weitere Informationen über Sapheon finden Sie unter www.sapheoninc.com.

Fotos/Multimedia-Galerie verfügbar unter: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50405526&lang=de

Die Ausgangssprache, in der der Originaltext veröffentlicht wird, ist die offizielle und autorisierte Version. Übersetzungen werden zur besseren Verständigung mitgeliefert. Nur die Sprachversion, die im Original veröffentlicht wurde, ist rechtsgültig. Gleichen Sie deshalb Übersetzungen mit der originalen Sprachversion der Veröffentlichung ab.

« Les résultats de notre étude eSCOPE indiquent que VenaSeal offre aux patients une option de traitement plus agréable »

Selon Sapheon, toutes les procédures ont été réussies au moment du traitement, avec une fermeture de 100 % observée par échographie. À ce jour, 60 patients ont participé à des visites de suivi à 30 jours, et 26 patients à des visites de suivi à 90 jours, avec des taux de fermeture respectifs de 100 et 96 %. Aucun événement indésirable grave n'a été rapporté dans cette étude. Ces résultats sont en cohérence avec les données accumulées sur un an dans le cadre de l'étude de faisabilité, menée auprès de 38 patients humains et publiée par Sapheon plus tôt cet été.

Le Dr Jens Alm, du Dermatologikum Hambourg en Allemagne et chercheur dans le cadre de l'étude eSCOPE, a déclaré : « Mon impression est que les patients bénéficient d'une expérience de vie de meilleure qualité après la procédure VenaSeal par rapport aux patients soumis à des techniques d'ablation thermique de la veine. Mes patients n'ont souffert d'aucune gêne postintervention et n'ont pas eu besoin de porter d'inconfortables bas de contention. Ils ont été en mesure de reprendre immédiatement des activités quotidiennes normales. »

« Les résultats de notre étude eSCOPE indiquent que VenaSeal offre aux patients une option de traitement plus agréable », a déclaré Rod Raabe, docteur en médecine, président et chef des services médicaux de Sapheon. « Le système de fermeture VenaSeal de Sapheon constitue de toute évidence un traitement efficace permettant d'éliminer la douleur significative, l'anesthésie tumescente, les bas de contention, ainsi que de réduire les durées élevées de convalescence associées aux thérapies par ablation. Nous sommes désormais impatients de proposer aux médecins cette procédure améliorée de traitement des patients atteints d'une maladie fréquente qui entraîne veines variqueuses douloureuses et jambes disgracieuses. »

À propos de Sapheon

Sapheon Inc. est une société de droit privé spécialisée dans les dispositifs médicaux, et dont la mission consiste à élaborer de nouvelles approches dans le traitement des maladies vasculaires. La société met actuellement l'accent sur une option de traitement avancée des troubles du retour sanguin, qui représente un marché mondial d'un milliard de dollars. Sapheon a obtenu l'approbation réglementaire de l'Union européenne pour le système de fermeture VenaSeal™ Sapheon®. À ce jour, le système de fermeture VenaSeal Sapheon n'est pas encore commercialisé aux États-Unis. Veuillez visiter www.sapheoninc.com pour en savoir davantage sur Sapheon.

Photos/galerie multimédia disponibles : http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50405526&lang=fr

Le texte du communiqué issu d’une traduction ne doit d’aucune manière être considéré comme officiel. La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.